ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Renal function"

  • 2018 American Transplant Congress

    Kidney Transplantation from Uncontrolled Donation after Circulatory Death, Good Outcomes after Very Long Time

    M. Molina,1 J. Cabrera,2 E. Gonzalez,1 A. Hernandez,1 P. Natalia,1 A. Andres.1

    1Department of Nephrology, Hospital Universitario 12 de Octubre, Madrid, Spain; 2Department of Nephrology, Hospital Evangelico, Montevideo, Uruguay.

    Introduction: Kidney transplantation (KT) is the best renal replacement therapy but the shortage of organ is the main limitation. Uncontrolled Donation after Circulatory Death (uDCD)…
  • 2018 American Transplant Congress

    Everolimus with Reduced-Dose Calcineurin Inhibitor versus Mycophenolate with Standard-Dose Calcineurin Inhibitor in De Novo Kidney Transplant Recipients: Renal Function Results from the TRANSFORM Study

    F. Oppenheimer,1 C. Legendre,1 J. Cruzado,1 G. Russ,1 O. Viklicky,1 R. Oberbauer,1 V. Garcia,1 O. Witzke,1 D. Kuypers,1 R. Danguilan,1 P. Bernhardt,2 C. Sommerer.1

    1TRANSFORM Study Group, Barcelona, Spain; 2Novartis Pharma AG, Basel, Switzerland.

    Purpose: TRANSFORM (NCT01950819) is the largest study conducted in de novo kidney transplant recipients (KTxRs) to evaluate the benefit of everolimus with reduced-dose calcineurin inhibitor…
  • 2018 American Transplant Congress

    Development of a Screening Tool to Predict Chronic Kidney Disease Risk in Post-Nephrectomy Living Kidney Donors

    J. Na,1 J. Park,1 M-.G. Yoon,1 H. Lee,2 Y. Yoon,3 K. Huh,4 M. Kim,4 S. Kim,4 Y. Kim,4 W. Han.1

    1Department of Urology, Yonsei University College of Medicine, Urological Science Institute, Seoul, Korea; 2Department of Urology, National Health Insurance Service Ilsan Hospital, Goyang-si, Korea; 3Department of Urology, Hanyang University Medical Center, Seoul, Korea; 4Department of Surgery-Transplantation, Yonsei University College of Medicine, Seoul, Korea.

    Purpose: We aimed to develop a prediction models of chronic kidney disease (CKD) for the 1-year period after donor nephrectomy in living donors.Materials and Methods:…
  • 2018 American Transplant Congress

    Technical Challenges in Living Donor Kidney Transplantation – Diagnosis and Solutions

    R. Öllinger,1 K. Alqasim,1 F. Klein,1 N. Raschzok,1 P. Ritschl,1 S. Chopra,1 N. Otto,2 T. Denecke,3 U. Gerlach,1 M. Schmelzle,1 P. Reinke,2 J. Pratschke.1

    1Department of Surgery, Charité, Berlin, Germany; 2Department of Nephrology, Charité, Berlin, Germany; 3Department of Radiology, Charité, Berlin, Germany.

    IntroductionDue to organ scarcity living donation is becoming a major source of kidneys for transplantation. Besides medical contraindications, anatomy of the kidneys may be a…
  • 2018 American Transplant Congress

    Allograft Function after 12 Months with Everolimus Plus Either Tacrolimus or Cyclosporine Compared to a Standard Regimen of Tacrolimus with MPA in De Novo Renal Transplant Recipients: The ATHENA Study

    B. Nashan,1 C. Sommerer,1 B. Suwelack,1 D. Dragun,1 O. Witzke,1 C. Hugo,1 N. Kamar,2 P. Merville,2 A. Hauser,1 P. Schenker,1 M. Junge,3 F. Thaiss.1

    1Athena Study Group, Germany; 2Athena Study Group, France; 3Novartis, Pharma, Germany.

    The ATHENA study was designed to compare efficacy, safety and outcomes on renal function [GFR] of everolimus [EVR] combined with tacrolimus [TAC] or cyclosporine A…
  • 2018 American Transplant Congress

    Long-Term Renal Function in Living Kidney Donors with Renal Cysts

    M. Waldram, A. Thomas, A. Muzaale, C. Holscher, A. Nguyen, S. Halpern, S. Anjum, J. Alejo, B. Boyarsky, S. Ottman, J. Garonzik-Wang, D. Segev, A. Massie.

    JHU, Baltimore.

    Renal cysts found during the evaluation of living kidney donor (LKD) candidates are often regarded as benign. However, it is possible that these structural abnormalities…
  • 2018 American Transplant Congress

    Liver Transplantation with or without Left Renal Vein Ligation: Comparative Study of 105 Cases

    M. Perosa,1 H. Noujaim,1 J. Branez,1 L. Mota,1 B. Zeballos,1 R. Santos,1 A. Watanabe,2 G. Ferreira,2 A. Moraes,2 A. Silvestre,3 G. Martinho,4 N. Siqueira,5 T. Genzini.1

    1Abdominal Organ Transplantation, Leforte Hospital, Sao Paulo, Brazil; 2ICDF Hospital, Brasilia, Brazil; 3Medical School, Sao Camilo, Sao Paulo, Brazil; 4Medical School, Santa Casa, Sao Paulo, Brazil; 5Hospital das Clínicas, Rio Branco, Acre, Brazil.

    The presence of large spontaneous splenorenal shunts (SSRS) is a risk factor for low portal flow and graft dysfunction after liver transplantation (LT). Left renal…
  • 2018 American Transplant Congress

    Ischemia Reperfusion Injury in Liver Transplantation is Associated with Acute Kidney Injury: Role of Inflammatory Mediators

    P. Mihaylov,1,2 P. Li,1 J. Skill,1 L. Timsina,1 J. Fridell,1 B. Ekser,1 R. Mangus,1 C. Kubal.1

    1Surgery, Indiana University, Indianapolis; 2Surgery, University of Pavia, Pavia, Italy.

    Background: The impact of liver allograft ischemia/reperfusion injury (IRI) on native renal function remains to be characterized. We hypothesized that elevated levels of circulating inflammatory…
  • 2018 American Transplant Congress

    Delayed Recovery of Renal Function after Donor Nephrectomy

    J. Na,1 J. Park,1 M-.G. Yoon,1 H. Lee,2 Y. Yoon,3 K. Huh,4 M. Kim,4 S. Kim,4 Y. Kim,4 W. Han.1

    1Department of Urology, Yonsei University College of Medicine, Urological Science Institute, Seoul, Korea; 2Department of Urology, National Health Insurance Service Ilsan Hospital, Goyang-si, Korea; 3Department of Urology, Hanyang University Medical Center, Seoul, Korea; 4Department of Surgery-Transplantation, Yonsei University College of Medicine, Seoul, Korea.

    Introduction:Among living kidney donors at risk of CKD at 1 year after nephrectomy, some donors remain with poor renal function while many show delayed recovery…
  • 2018 American Transplant Congress

    Outcomes in Liver Transplant Patients on Renal Sparing Protocol

    A. Polyak,1 D. Ganger,2 A. Shetty.2

    1New York Medical College, Valhalla, NY; 2Comprehensive Transplant Center, Northwestern University, Chicago, IL.

    As liver transplant outcomes have improved, long term native kidney function has taken a critical role in patient survival. Calcineurin inhibitors (CNIs), such as Tacrolimus…
  • « Previous Page
  • 1
  • …
  • 12
  • 13
  • 14
  • 15
  • 16
  • …
  • 27
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences